MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Drugs.com - Pharma News' source. Thu, 09 Feb 2012 01:31:31 +0100 http://www.medworm.com/index.php?rid=5669395&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FPSgmpnXlLKY%2Fproton-pump-inhibitors-ppis-safety-communication-clostridum-difficile-associated-diarrhea-cdad-can-36340.html AcipHex (rabeprazole sodium)  Dexilant (dexlansoprazole)   Nexium (esomeprazole magnesium)?   Omeprazole (omeprazole) Over-the-Counter (OTC)   Prevacid (lansoprazole) and OTC Prevacid 24hr   Prilosec (omeprazole)? and OTC... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669395 Wed, 08 Feb 2012 16:15:56 +0100 5669395 http://www.medworm.com/index.php?rid=5669396&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fxvri0DII8mw%2Fgsk-adjusting-r-amp-d-efforts-36341.html GSK adjusting its R&D efforts [The News & Observer, Raleigh, N.C.] From News & Observer (Raleigh, NC) (February 8, 2012) Feb. 08--GlaxoSmithKline's plans for reconfiguring its research-and-development efforts aim to... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669396 Wed, 08 Feb 2012 15:14:17 +0100 5669396 http://www.medworm.com/index.php?rid=5669397&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FyEJth2pTvmo%2Fcollege-vending-machine-dispenses-morning-after-pill-36339.html Pa. vending machine dispenses 'morning-after' pill From Associated Press (February 8, 2012) Students at Shippensburg University in Pennsylvania can get the "morning-after" pill by sliding $25 into a vending machine, an idea that has drawn... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669397 Wed, 08 Feb 2012 14:02:11 +0100 5669397 http://www.medworm.com/index.php?rid=5669398&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F2D0Ahd1asPc%2Fsanofi-2011-results-benefit-genzyme-acquisition-36333.html Net Sales and Business EPS(1) up 9.2%(2) in Q4 PARIS, February 08, 2012, 2012 /PRNewswire/ --   (Logo : http://photos.prnewswire.com/prnh/20110616/NY20158LOGO )     Change at ... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669398 Wed, 08 Feb 2012 12:35:11 +0100 5669398 http://www.medworm.com/index.php?rid=5669399&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FverW0iYO5Zk%2Froche-disappointed-actions-illumina-inc-s-board-directors-36334.html Roche's offer provides full and fair value for Illumina shareholders BASEL, Switzerland--(BUSINESS WIRE)--Feb 8, 2012 - Roche (SIX: RO, ROG; OTCQX: RHHBY) released the following statement in response to the announcement by Illumina, Inc. (NASDAQ:... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669399 Wed, 08 Feb 2012 12:31:01 +0100 5669399 http://www.medworm.com/index.php?rid=5669400&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FM3PyPTlsCuE%2Fsanofi-bristol-myers-squibb-collect-damages-plavix-patent-litigation-apotex-36335.html PARIS & NEW YORK--(BUSINESS WIRE)--Feb 8, 2012 - Sanofi (EURONEXT: SAN and NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that Apotex has made payment in the amount of $442,209,362 to Sanofi and Bristol-Myers Squibb to... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669400 Wed, 08 Feb 2012 12:29:42 +0100 5669400 http://www.medworm.com/index.php?rid=5669401&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FrOmrgcFOw-g%2Ffda-speed-up-review-roche-cancer-36331.html From Associated Press (February 7, 2012) NEW YORK -- Swiss drugmaker Roche said Tuesday that the Food and Drug Administration will make a decision on its experimental breast cancer drug pertuzumab by June. Roche's Genentech business aid the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669401 Wed, 08 Feb 2012 12:02:22 +0100 5669401 http://www.medworm.com/index.php?rid=5669402&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FYory0L8YxTo%2Fsanofi-wins-us-approval-anti-lice-shampoo-36332.html From Associated Press (February 7, 2012) WASHINGTON -- Drugmaker Sanofi said Tuesday it received U.S. approval for a prescription-strength shampoo to treat head lice in children six months old and up. The company's Sklice Lotion uses a... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669402 Wed, 08 Feb 2012 12:02:06 +0100 5669402 http://www.medworm.com/index.php?rid=5669403&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FDEpIdEc0YoE%2Fillumina-s-board-unanimously-rejects-roche-s-unsolicited-tender-offer-inadequate-36327.html Urges Stockholders Not to Tender Their Shares Files 14D-9 with SEC Detailing Reasons for Board's Recommendation Hosts Conference Call for Investors at 5:00 PM ET SAN DIEGO--(BUSINESS WIRE)--Feb 7, 2012 - Illumina, Inc. (NASDAQ:ILMN), a leading... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669403 Tue, 07 Feb 2012 21:34:23 +0100 5669403 http://www.medworm.com/index.php?rid=5669404&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F-2aggYuQDIo%2Fgsk-upbeat-solid-results-interviews-ceo-cfo-36314.html LONDON, February 7, 2012/PRNewswire-FirstCall/ -- In an online video interview with MerchantCantos, GlaxoSmithKline CEO Sir Andrew Witty talks about the pharmaceutical group's special dividend, solid results and why the company is so well positioned... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669404 Tue, 07 Feb 2012 16:25:50 +0100 5669404 http://www.medworm.com/index.php?rid=5669405&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FK2yPWnh1WsY%2Fedarbyclor-azilsartan-medoxomil-chlorthalidone-now-available-u-s-pharmacies-patients-hypertension-36313.html DEERFIELD, Ill., February 6, 2012 and Osaka, Japan, February 7, 2012 – Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced EDARBYCLOR (azilsartan medoxomil and... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669405 Tue, 07 Feb 2012 14:02:31 +0100 5669405 http://www.medworm.com/index.php?rid=5669406&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FA1QXQnRkhTQ%2Fglaxosmithkline-shares-edge-lower-fourth-quarter-figures-prove-slight-disappointment-36307.html Guardian Web (February 7, 2012)   GlaxoSmithKline's results are out and they seem to have slightly disappointed the market.   The pharmaceuticals group said fourth quarter turnover was down 3% at £6.98bn with earnings per share... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669406 Tue, 07 Feb 2012 13:16:51 +0100 5669406 http://www.medworm.com/index.php?rid=5669407&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FtEDJ1iHcB4E%2Famylin-takes-4q-loss-lilly-partnership-ends-36308.html   From Associated Press (February 7, 2012)     SAN DIEGO -- Diabetes drug maker Amylin Pharmaceuticals Inc. reported a larger fourth-quarter loss Monday after it ended a partnership with Eli Lilly & Co., which gave Amylin all the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669407 Tue, 07 Feb 2012 13:11:20 +0100 5669407 http://www.medworm.com/index.php?rid=5669408&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FFs3IKpJVZF8%2Fprevents-breast-cancer-some-women-hard-bones-study-36306.html From Canadian Press DataFile (February 6, 2012) By Sheryl Ubelacker TORONTO _ A drug shown to be highly effective in preventing breast cancer in postmenopausal women at high risk for the disease appears to worsen age-related bone loss, despite... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669408 Tue, 07 Feb 2012 13:02:37 +0100 5669408 http://www.medworm.com/index.php?rid=5669409&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fja6PRJ7Jw3M%2Fcipher-achieves-sales-milestone-lipofen-36292.html   www.cipherpharma.com. carmitage@equicomgroup.com Larry Andrews President and CEO Cipher Pharmaceuticals (905) 602-5840 ext 324 (905) 602-0628 faxlandrews@cipherpharma.com             Craig Armitage Investor... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669409 Mon, 06 Feb 2012 17:37:21 +0100 5669409 http://www.medworm.com/index.php?rid=5669410&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FnOKSEVXCxZI%2Fcegedim-strategic-data-csd-tracks-pharmaceutical-companies-print-advertising-investments-36286.html Rate of Decline in Print Advertising Investments Slows to 4% for 12 Months Ending September 2011 Across Ten Key Markets PARIS--(Marketwire - Feb 6, 2012) - Cegedim Strategic Data (CSD) (www.cegedimstrategicdata.com), leading provider of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669410 Mon, 06 Feb 2012 14:06:53 +0100 5669410 http://www.medworm.com/index.php?rid=5669411&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F1CMl_2BgXLw%2Fmerck-provides-update-development-program-suvorexant-investigational-orexin-receptor-antagonist-36288.html Company Confirms Plans to File NDA for Suvorexant in 2012 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Feb 6, 2012 - Merck (NYSE:MRK), known as MSD outside the United States and Canada, today provided an update on the development program for... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669411 Mon, 06 Feb 2012 13:58:00 +0100 5669411 http://www.medworm.com/index.php?rid=5669412&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FYA71JEqeGgY%2Fanacor-pharmaceuticals-announces-partner-gsk-has-voluntarily-paused-enrollment-ongoing-gsk-052-36287.html PALO ALTO, Calif.--(BUSINESS WIRE)--Feb 6, 2012 - Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that its partner GlaxoSmithKline (GSK) has voluntarily paused enrollment in its current clinical trials of GSK2251052 (GSK ˜052) due to... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669412 Mon, 06 Feb 2012 13:57:39 +0100 5669412 http://www.medworm.com/index.php?rid=5669413&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FvdbisHSC5rA%2Fastellas-pharma-inc-reorganization-astellas-global-management-structure-36283.html February 6, 2012 Astellas Pharma Inc.: Reorganization of Astellas’Global Management Structure Astellas Pharma Inc. (Headquarters: Tokyo, President and CEO: Yoshihiko Hatanaka, “Astellas”) announced that it will implement revisions... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669413 Mon, 06 Feb 2012 13:41:22 +0100 5669413 http://www.medworm.com/index.php?rid=5669414&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FpmeNAwsYJl4%2Ffive-years-after-hpv-vaccine-law-virginia-remains-split-36285.html Five Years After HPV Vaccine Law, State Remains Split [Virginian - Pilot] From Virginian - Pilot (February 5, 2012) By Elizabeth Simpson | The Virginian-Pilot Tonya McKinney was so intent on her daughter receiving the human papillomavirus... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669414 Mon, 06 Feb 2012 13:02:59 +0100 5669414 http://www.medworm.com/index.php?rid=5669415&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F0A9V8uZizFI%2Fpharma-cos-need-compensate-clinical-trial-victims-rules-govt-36284.html Pharma cos need to compensate clinical trial victims, rules govt [Financial Express (India)] From Financial Express (India) (February 3, 2012) The government has made it mandatory for pharmaceutical companies sponsoring clinical trials in the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669415 Mon, 06 Feb 2012 12:59:48 +0100 5669415 http://www.medworm.com/index.php?rid=5669416&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F1zWypbsVZt4%2Fcardinal-health-statement-regarding-temporary-restraining-order-avoid-disruption-controlled-36279.html       DUBLIN, Ohio, Feb. 3, 2012 /PRNewswire/ -- Today Cardinal Health was granted a temporary restraining order against the Drug Enforcement Administration's (DEA) immediate suspension order of its Lakeland, Fla. DEA... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5669416 Mon, 06 Feb 2012 12:10:41 +0100 5669416 http://www.medworm.com/index.php?rid=5661343&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FduQYD4m5Q24%2Fcardinal-health-inc-seeks-restraining-order-avoid-disruption-controlled-medicine-shipments-florida-36264.html DUBLIN, Ohio, Feb. 3, 2012 /PRNewswire/ -- Cardinal Health, one of the nation's largest health care distributors, today said it will vigorously contest the Drug Enforcement Administration's (DEA) immediate suspension of its license to distribute... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5661343 Fri, 03 Feb 2012 17:16:14 +0100 5661343 http://www.medworm.com/index.php?rid=5661344&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FX1yMxijNWMU%2Fmontreal-pharma-research-cluster-threatened-again-astrazeneca-closes-lab-36258.html From Canadian Press DataFile (February 2, 2012) By Ross Marowits MONTREAL -- Montreal’s status as a pharmaceutical research centre is under further threat as global giants adjust to the loss of patent protection for blockbuster drugs and... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5661344 Fri, 03 Feb 2012 15:11:04 +0100 5661344 http://www.medworm.com/index.php?rid=5661345&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FRab_6E8RAoo%2Ffederal-court-dismisses-whistleblower-lawsuit-against-millennium-laboratories-36256.html Millennium Leads Industry Initiative and Calls on Other Laboratories to Implement Higher Compliance Standards; Funds a National Summit Chaired by Dr. Richard Payne, Professor of Medicine and Divinity at Duke University for Establishment of Industry... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5661345 Fri, 03 Feb 2012 13:52:01 +0100 5661345 http://www.medworm.com/index.php?rid=5661346&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FKCTcrZREVRE%2Fidenix-announces-removal-partial-clinical-hold-hcv-nucleotide-inhibitor-idx184-36257.html CAMBRIDGE, Mass., Feb. 3, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has received... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5661346 Fri, 03 Feb 2012 13:12:21 +0100 5661346 http://www.medworm.com/index.php?rid=5661347&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FXGChsWiMQpQ%2Fbristol-myers-squibb-announces-expiration-hart-scott-rodino-waiting-period-acquisition-inhibitex-inc-36248.html NEW YORK--(BUSINESS WIRE)--Feb 3, 2012 - Bristol-Myers Squibb Company (NYSE: BMY) announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended (HSR) for its tender offer for Inhibitex, Inc.... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5661347 Fri, 03 Feb 2012 12:41:34 +0100 5661347 http://www.medworm.com/index.php?rid=5661348&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FZ3Rt1MwqT4s%2Fgilead-sciences-announces-fourth-quarter-full-year-2011-financial-results-36251.html - Fourth Quarter Product Sales of $2.13 Billion, up 11% Year over Year - - Full Year 2011 Product Sales of $8.10 Billion, up 10% over 2010 - - Full Year 2011 Non-GAAP EPS of $3.86, up 5% over 2010 - - Full Year 2011 Operating Cash Flows of $3.64... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5661348 Fri, 03 Feb 2012 12:25:39 +0100 5661348 http://www.medworm.com/index.php?rid=5661349&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fr-3_NSTk9J8%2Fmaker-alkermes-fiscal-3q-loss-widens-36252.html From Associated Press (February 2, 2012) Drug maker Alkermes PLC’s fiscal third-quarter loss widened as operating expenses ballooned compared to the previous year’s quarter, before the company had completed its acquisition of Elan... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5661349 Fri, 03 Feb 2012 12:09:22 +0100 5661349 http://www.medworm.com/index.php?rid=5661350&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fbc8clku7MtQ%2Fgilead-sciences-4q-profit-rises-hiv-sales-36250.html From Associated Press (February 2, 2012) FOSTER CITY, Calif. -- Gilead Sciences Inc.'s profit grew 6 percent in the fourth quarter on greater sales of its HIV drugs including Atripla. Gilead said Thursday that its profit rose to $665.1 million, or... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5661350 Fri, 03 Feb 2012 12:08:50 +0100 5661350 http://www.medworm.com/index.php?rid=5661351&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FSWLMmpeoSLw%2Fvertex-posts-4q-profit-growing-incivek-sales-36249.html From Associated Press (February 2, 2012) CAMBRIDGE, Mass. -- Drugmaker Vertex Pharmaceuticals Inc. said Thursday it turned a profit in the fourth quarter on sales of its hepatitis C pill Incivek, which was approved in May. Vertex reported a profit... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5661351 Fri, 03 Feb 2012 12:08:43 +0100 5661351 http://www.medworm.com/index.php?rid=5661352&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fy-mKvw1o3EE%2Fmerck-kgaa-threshold-announce-global-agreement-co-develop-commercialize-phase-iii-hypoxia-targeted-36247.html Phase III soft tissue sarcoma trial ongoing; randomized Phase II pancreatic cancer trial expected to report in February 2012 Deal provides Threshold with an upfront payment of ‚¬ 19 million ($25 million), plus further potential milestones... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5661352 Fri, 03 Feb 2012 11:39:54 +0100 5661352 http://www.medworm.com/index.php?rid=5651490&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FSNBs-Ch2UE4%2Fmikulski-bill-would-speed-approval-new-fda-36230.html Mikulski bill would speed approval of new drugs by FDA [The Baltimore Sun] From Baltimore Sun (MD) (February 2, 2012) Feb. 02--WASHINGTON -- Drugs for chronic conditions such as Alzheimer's disease and diabetes would move through the Food and Drug... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651490 Thu, 02 Feb 2012 15:06:22 +0100 5651490 http://www.medworm.com/index.php?rid=5651491&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FvnEfJSPsgSE%2Fallergan-reports-fourth-quarter-2011-operating-results-36229.html Board of Directors Declares Fourth Quarter Dividend IRVINE, Calif.--(BUSINESS WIRE)--Feb 2, 2012 - Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended December 31, 2011. Allergan also announced that its Board... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651491 Thu, 02 Feb 2012 14:12:21 +0100 5651491 http://www.medworm.com/index.php?rid=5651492&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FyRmYz1t1ykc%2Fwe-sure-our-safe-36228.html [St. Joseph News-Press (MO)] From St. Joseph News-Press (MO) (February 1, 2012) (CNN) -- When Americans pick up their prescriptions from the pharmacy or reach for a prescription bottle from their medicine cabinet,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651492 Thu, 02 Feb 2012 13:02:58 +0100 5651492 http://www.medworm.com/index.php?rid=5651493&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FEJLd41we3GA%2Fnovo-nordisk-increased-operating-profit-18-2011-36227.html Sales growth of 9% driven by Victoza®, NovoRapid® and Levemir®     * Sales increased by 11% in local currencies and by 9% in Danish kroner.           o Sales of modern insulins... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651493 Thu, 02 Feb 2012 13:00:24 +0100 5651493 http://www.medworm.com/index.php?rid=5651494&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FE9t5BQUVrp8%2Fmerck-announces-full-year-fourth-quarter-2011-financial-results-36218.html 2011 Full-Year Non-GAAP EPS of $3.77, Excluding Certain Items; GAAP EPS of $2.02; Fourth-Quarter Non-GAAP EPS of $0.97, Excluding Certain Items; GAAP EPS of $0.49 2011 Full-Year Worldwide Sales Grew Four Percent to $48.0 Billion, Including Two... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651494 Thu, 02 Feb 2012 12:32:33 +0100 5651494 http://www.medworm.com/index.php?rid=5651495&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FocYzb6NjYLg%2Fastrazeneca-s-new-restructuring-initiatives-drive-productivity-support-innovation-36219.html Thursday, 2 February 2012 In conjunction with the publication of its full year 2011 results earlier today, AstraZeneca announced new restructuring initiatives designed to improve productivity and strengthen the company’s commercial, operations... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651495 Thu, 02 Feb 2012 12:24:02 +0100 5651495 http://www.medworm.com/index.php?rid=5651496&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FJNJRPQDkeaI%2Fagennix-ag-halts-phase-ii-iii-oasis-trial-severe-sepsis-36220.html PLANEGG, GERMANY and MUNICH, GERMANY--(Marketwire - Feb 2, 2012) - Agennix AG (FRANKFURT: AGX) (XETRA: AGX) (ISIN DE000A1A6XX4) announced that, upon the recommendation of the study Data Safety Monitoring Board (DSMB), the Company has stopped further... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651496 Thu, 02 Feb 2012 12:10:51 +0100 5651496 http://www.medworm.com/index.php?rid=5651497&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FFPui4Y5TkqA%2Findependent-survey-us-oncologists-national-analysts-worldwide-finds-shortages-escalating-costs-36212.html Nearly half of surveyed oncologists saw tumors recur and patients die sooner due to drug shortages; 73 percent substituted sub-optimal care due to patient inability to afford drug co-payments   PHILADELPHIA--(BUSINESS WIRE)--Feb 1, 2012 - A... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651497 Wed, 01 Feb 2012 19:02:36 +0100 5651497 http://www.medworm.com/index.php?rid=5651498&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FUVcfawsBe9U%2Fwhich-pharma-leading-charge-productive-innovation-2012-36204.html IDEA Pharma has launched the second annual Productive Innovation Index (PII), ranking 21 global pharmaceutical companies for their ability to add value to, and derive value from, molecules in pre-launch. The word “innovation” is often... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651498 Wed, 01 Feb 2012 17:46:09 +0100 5651498 http://www.medworm.com/index.php?rid=5651499&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F_eYjVRUoQow%2Fpfizer-evp-among-obama-top-money-bundlers-36197.html Obama releases list of top money 'bundlers' From Associated Press (February 1, 2012) WASHINGTON -- President Barack Obama's re-election campaign identified its top fundraisers on Tuesday, including 61 people who each raised at least half a million... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651499 Wed, 01 Feb 2012 14:51:18 +0100 5651499 http://www.medworm.com/index.php?rid=5651500&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fh305xmx1Sh4%2Fd-amp-r-acquires-lathian-create-leading-multichannel-marketing-agency-36196.html New Combined Entity Delivers Strategic Multichannel Marketing Services Under One Roof for Pharmaceutical Companies to Increase Brand Performance at Any Stage of their Product Lifecycle SHREWSBURY, N.J. & LAKE FOREST, Calif.--(BUSINESS... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651500 Wed, 01 Feb 2012 14:50:23 +0100 5651500 http://www.medworm.com/index.php?rid=5651501&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F6HUPKVcTueI%2Fstudy-e-shown-improve-outcomes-save-u-s-healthcare-billions-dollars-36198.html ARLINGTON, VA -- (MARKET WIRE) -- 02/01/12 -- Surescripts, the nation's e-prescription network, today announced study findings from de-identified data that link e-prescribing to a significant increase in first-fill medication adherence. Poor... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651501 Wed, 01 Feb 2012 14:25:25 +0100 5651501 http://www.medworm.com/index.php?rid=5651502&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FFgDomwW1vi4%2Fshire-sangamo-collaborate-develop-therapeutics-hemophilia-other-monogenic-diseases-36185.html DUBLIN and RICHMOND, California, February 1, 2012 /PRNewswire/ -- - Partnership in DNA-binding technology has potential to provide both companies growth through innovation of new therapies for people with serious diseases Shire plc (LSE: SHP,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651502 Wed, 01 Feb 2012 12:23:40 +0100 5651502 http://www.medworm.com/index.php?rid=5651503&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FHoNc91Yv1vg%2Froche-2011-strong-results-positive-outlook-36186.html Group sales rise 2% 1 (-10% in Swiss francs; +6% in US dollars), excluding Tamiflu. Significant foreign exchange impact of –12 percentage points due to appreciation of the Swiss franc; overall Group sales at 42.5 billion Swiss... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651503 Wed, 01 Feb 2012 12:23:22 +0100 5651503 http://www.medworm.com/index.php?rid=5651504&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FLd3v4LmPqro%2Fucb-astellas-announce-agreement-jointly-develop-commercialize-cimzia-certolizumab-pegol-japan-36187.html Astellas and UCB partner to bring certolizumab pegol to rheumatoid arthritis patients in Japan UCB files certolizumab pegol for marketing authorisation with the Japanese Ministry of Health, Labour and Welfare Tokyo, Japan and Brussels, Belgium, 1st... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651504 Wed, 01 Feb 2012 12:10:11 +0100 5651504 http://www.medworm.com/index.php?rid=5651505&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fo8kMjROXw2A%2Fpfizer-announces-voluntary-nationwide-recall-lo-ovral-28-norgestrel-ethinyl-estradiol-due-36189.html NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today that it has voluntarily recalled 14 lots of Lo/Ovral-28 (norgestrel and ethinyl estradiol)Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic)for customers in the U.S.... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651505 Wed, 01 Feb 2012 12:02:03 +0100 5651505 http://www.medworm.com/index.php?rid=5651506&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FRQwGyWd6HEY%2Fdendreon-announces-ceo-chairman-succession-plan-36188.html John H. Johnson Elected President, Chief Executive Officer and Chairman-Elect, Dr. Mitchell H. Gold Elected Executive Chairman Company to Hold Conference Call Today at 9:00 a.m. ET/6:00 a.m. PT SEATTLE--(BUSINESS WIRE)--Feb 1, 2012 - February 1,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651506 Wed, 01 Feb 2012 11:48:02 +0100 5651506 http://www.medworm.com/index.php?rid=5651507&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FmWSvCdO0sDI%2Froche-nominates-directors-illumina-board-36183.html From Associated Press (January 31, 2012) SAN DIEGO -- Swiss drugmaker Roche said Tuesday that it plans to nominate a slate of directors to the board of Illumina Inc., a diagnostics company Roche is trying to buy. On Friday Roche went public with an... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651507 Wed, 01 Feb 2012 11:47:31 +0100 5651507 http://www.medworm.com/index.php?rid=5651508&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FoBLPtnU-6Ok%2Fmannkind-falls-stock-debt-offerings-36184.html From Associated Press (February 1, 2012) VALENCIA, Calif. -- Diabetes drug developer MannKind Corp. said Tuesday it plans to offer $50 million in stock and as much as $161 million in debt. MannKind said it intends to sell units made up of one share... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651508 Wed, 01 Feb 2012 11:41:37 +0100 5651508 http://www.medworm.com/index.php?rid=5651509&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FYkyytFydv1U%2Fsigma-aldrich-completes-acquisition-bioreliance-36175.html     ST. LOUIS, Jan. 31, 2012 /PRNewswire/ -- From: Rakesh Sachdev, President and CEO: Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company, announced it has completed its acquisition of ... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651509 Tue, 31 Jan 2012 22:22:27 +0100 5651509 http://www.medworm.com/index.php?rid=5651510&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FyhjMXhKsT1s%2Fmonthly-roundup-january-2012-36173.html Bydureon Approved: First Once-A-Week Treatment for Type 2 Diabetes Amylin Pharmaceuticals received FDA-approval of Bydureon (exenatide extended-release for injectable suspension), a once-a-week, 2 mg injection used in conjunction with diet and... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651510 Tue, 31 Jan 2012 22:01:03 +0100 5651510 http://www.medworm.com/index.php?rid=5651511&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F3jMfRyENhIg%2Froche-nominate-slate-independent-directors-election-illumina-inc-s-2012-annual-meeting-36163.html Election of director nominees and approval of other proposals would result in Roche-nominated directors comprising majority of the Board BASEL, Switzerland--(BUSINESS WIRE)--Jan 31, 2012 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651511 Tue, 31 Jan 2012 19:51:54 +0100 5651511 http://www.medworm.com/index.php?rid=5651512&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FTqEhwKE0JG4%2Forexo-s-discovery-collaboration-terminated-ox-cli-ox-esi-projects-end-36164.html Uppsala – January 31, 2012 - Orexo AB and Janssen Pharmaceuticals, Inc., formerly Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV ("Janssen"), have decided to end their research collaboration and license agreement... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651512 Tue, 31 Jan 2012 15:46:13 +0100 5651512 http://www.medworm.com/index.php?rid=5651513&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fbgxysmd8cK4%2Fisotechnika-terminates-existing-agreement-iljin-36165.html Company Secures Rights and Seeks More Favourable License Agreement???? ? EDMONTON, Alberta, January 31, 2012 - Consistent with prior communications from ILJIN, the company is pursuing discussions with ILJIN Life Science Co., Ltd. ("ILJIN") to... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651513 Tue, 31 Jan 2012 13:29:31 +0100 5651513 http://www.medworm.com/index.php?rid=5651514&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FlGkvm69ZgeQ%2Fupdated-status-daiichi-sankyo-priority-development-projects-36166.html TOKYO, January 31, 2012 — Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced an update on the current status of clinical trials for the priority development pipeline projects involving edoxaban, prasugrel, and... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651514 Tue, 31 Jan 2012 13:28:29 +0100 5651514 http://www.medworm.com/index.php?rid=5651515&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F4qaCkfJJHGs%2Fcosts-rise-much-7-percent-some-settings-2012-36171.html ASHP's Annual Projection Forecasts Expenditures for Drugs in Outpatient, Clinics, and Hospital Settings BETHESDA, Md. — Costs for medications will continue to rise in 2012 by as much as seven percent, according to a report published online... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651515 Tue, 31 Jan 2012 13:15:11 +0100 5651515 http://www.medworm.com/index.php?rid=5651516&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FNk_9G7_izN4%2Fbiosante-pharmaceuticals-provides-corporate-update-36167.html LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Jan 31, 2012 - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced a corporate update. Corporate development: In light of the recently announced top-line results from BioSante's two pivotal Phase III... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651516 Tue, 31 Jan 2012 13:14:47 +0100 5651516 http://www.medworm.com/index.php?rid=5651517&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FFujJ1R7cYT8%2Flilly-reports-fourth-quarter-full-year-2011-results-36168.html INDIANAPOLIS, January 31, 2012, 2012 /PRNewswire/ --Eli Lilly and Company today announced financial results for the fourth quarter and full year of 2011.     $in millions, except per share data    ... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651517 Tue, 31 Jan 2012 13:08:26 +0100 5651517 http://www.medworm.com/index.php?rid=5651518&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FHwvKxVJCPr0%2Fbiogen-idec-surpasses-5-billion-2011-annual-revenue-36170.html -- Non-GAAP Diluted EPS Rises 15% and GAAP Diluted EPS Up 28% -- -- Preparing for BG-12 Filing in First Half of 2012 -- -- Phase III data Anticipated in 2012 for Long-Lasting Factor VIII and Factor IX in Hemophilia and Dexpramipexole in... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651518 Tue, 31 Jan 2012 13:01:40 +0100 5651518 http://www.medworm.com/index.php?rid=5651519&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FvPWROKTzB80%2Fpfizer-reports-fourth-quarter-full-year-2011-results-updates-2012-financial-guidance-36169.html Fourth-Quarter 2011 Revenues of $16.7 Billion; Full-Year 2011 Revenues of $67.4 Billion Fourth-Quarter 2011 Adjusted Diluted EPS(1) of $0.50, Reported Diluted EPS(2) of $0.19; Full-Year 2011 Adjusted Diluted EPS(1) of $2.31, Reported Diluted EPS(2)... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651519 Tue, 31 Jan 2012 13:01:25 +0100 5651519 http://www.medworm.com/index.php?rid=5651520&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fzi46AoivuwE%2Fwatson-announces-new-jersey-based-global-r-amp-d-technology-center-36140.html - New Facility to Support Generic Pharmaceutical Product Development; Employ Approximately 50 Scientists, Chemists, Engineers, and Support Staff - PARSIPPANY, N.J., Jan. 30, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651520 Mon, 30 Jan 2012 17:11:00 +0100 5651520 http://www.medworm.com/index.php?rid=5651521&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FTxKoxSwwFyM%2Fubm-canon-pharmaceutical-group-announces-realignment-future-growth-36136.html   daniel.becker@ubm.com or Sandra Baker at sandra.baker@ubm.com or Andrew McSherry at andrew.mcsherry@ubm.com   chris.truelove@ubm.com or Andrew Humphreys at andrew.humphreys@ubm.com or Ed Silverman at ed.silverman@ubm.com. About UBM... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651521 Mon, 30 Jan 2012 16:22:53 +0100 5651521 http://www.medworm.com/index.php?rid=5651522&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FUuFhF8NJIUI%2Fjohnson-amp-johnson-joins-public-private-partners-largest-coordinated-action-date-eliminate-control-36137.html Advances R&D to develop new treatments and interventions Expands and extends donation of deworming medication LONDON, Jan. 30 2012 /PRNewswire/ -- Today Johnson & Johnson joined the World Health Organization (WHO), 12 other... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651522 Mon, 30 Jan 2012 14:22:00 +0100 5651522 http://www.medworm.com/index.php?rid=5651523&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FaMJhAf4ZFms%2Fvaleant-pharmaceuticals-withdraws-offer-acquisition-ista-pharmaceuticals-inc-36139.html MISSISSAUGA, Ontario, Jan. 30, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has withdrawn its offer to acquire ISTA Pharmaceuticals Inc. (Nasdaq: ISTA) for $7.50 per share in... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651523 Mon, 30 Jan 2012 13:59:36 +0100 5651523 http://www.medworm.com/index.php?rid=5651524&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fvnkyf0858A8%2Fshionogi-establishes-developmental-subsidiary-eu-36138.html Osaka, Japan, January 30, 2012 - Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) today announced it has decided to establish its 100%owned subsidiary “Shionogi... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5651524 Mon, 30 Jan 2012 13:59:35 +0100 5651524 http://www.medworm.com/index.php?rid=5631179&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F9uTnPxbmWis%2Fastrazeneca-amp-karolinska-institutet-announce-molecular-imaging-research-agreement-36097.html   AstraZeneca and Karolinska Institutet today announced a three year collaborative research agreement that will apply state-of-the-art molecular imaging technologies to generate novel diagnostic imaging tools and further the development of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5631179 Thu, 26 Jan 2012 19:07:49 +0100 5631179 http://www.medworm.com/index.php?rid=5631180&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FZj-uIk6qf7U%2Fbristol-myers-squibb-delivers-solid-fourth-quarter-capping-year-highlighted-new-product-approvals-36092.html Net Sales Rise 7% to $5.5 Billion in Fourth Quarter GAAP EPS Increases 79% to $0.50 in the Fourth Quarter; Non-GAAP EPS Increases 13% to $0.53 Demonstrates Commitment to Hepatitis C with Planned Acquisition of Inhibitex Provides 2012 GAAP and... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5631180 Thu, 26 Jan 2012 17:23:23 +0100 5631180 http://www.medworm.com/index.php?rid=5631181&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fc5-Hzgay7mg%2Fillumina-adopts-stockholder-rights-agreement-36093.html SAN DIEGO--(BUSINESS WIRE)--Jan 26, 2012 - Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function (the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5631181 Thu, 26 Jan 2012 17:08:00 +0100 5631181 http://www.medworm.com/index.php?rid=5631182&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fl8eULeId48U%2Fcelgene-acquire-avila-therapeutics-36094.html Oral Btk inhibitor AVL-292 offers promising potential for treatment of B-cell diseases Avilomics™ Platform enhances drug discovery capabilities   SUMMIT, N.J. and BEDFORD, Mass.--(BUSINESS WIRE)--Jan 26, 2012 - Celgene Corporation... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5631182 Thu, 26 Jan 2012 17:00:53 +0100 5631182 http://www.medworm.com/index.php?rid=5631183&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fy-DWuxeR5wY%2Fbaxter-reports-sales-eps-fourth-quarter-full-year-2011-line-guidance-36095.html Company Achieves Record Sales and Earnings in 2011 Baxter Provides Financial Outlook For 2012 DEERFIELD, Ill.--(BUSINESS WIRE)--Jan 26, 2012 - Baxter International Inc. (NYSE:BAX) today announced its financial results for the fourth quarter of 2011,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5631183 Thu, 26 Jan 2012 17:00:45 +0100 5631183 http://www.medworm.com/index.php?rid=5631184&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F05k0cHPnOik%2Fwatson-confirms-court-preliminary-injunction-36096.html - Permits Launch of Generic LOVENOX® - PARSIPPANY, N.J., Jan. 26, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), today confirmed that the United States Court of Appeals for the Federal Circuit has granted Watson and Amphastar... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5631184 Thu, 26 Jan 2012 16:54:30 +0100 5631184 http://www.medworm.com/index.php?rid=5631185&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fz5AGdo8_BPw%2Fsecond-city-communications-launches-video-service-sales-effectiveness-realbiz-shorts-sales-using-36070.html Leading Corporations Sign On to Innovative Service — Including Google, Pepsico, Allstate, MasterCard, & Xerox — Among Others RealBiz Shorts for Sales Adds The Second City's Trademark Humor To Help Make Sales Training Investments... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5631185 Wed, 25 Jan 2012 18:47:09 +0100 5631185 http://www.medworm.com/index.php?rid=5631186&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fxc9o1EMy6qA%2Fnovartis-delivers-strong-underlying-financial-performance-2011-expects-2012-sales-line-2011-36067.html • Fourth quarter sales rose 5% while core[1] operating income grew 17% in constant currencies (cc); full year sales up 12% cc and core operating income up 16% cc o Net sales increased 4% (+5% cc) to USD 14.8 billion; full year up 16% (+12% cc)... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5631186 Wed, 25 Jan 2012 17:30:27 +0100 5631186 http://www.medworm.com/index.php?rid=5631187&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FhJUA3R4BL3s%2Fjohnson-amp-johnson-reports-2011-fourth-quarter-full-year-results-36065.html 2011 Fourth-Quarter Sales of $16.3 Billion Increased 3.9%; EPS was $0.08 2011 Full-Year Sales of $65.0 Billion Increased 5.6%; Full-Year EPS was $3.49 Excluding Special Items, 2011 Fourth-Quarter EPS was $1.13, an Increase of 9.7%* And 2011... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5631187 Tue, 24 Jan 2012 15:21:01 +0100 5631187 http://www.medworm.com/index.php?rid=5631188&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FOphSs2WSy2w%2Fgenzyme-announces-fda-approval-framingham-manufacturing-plant-36066.html CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 24, 2012 - Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that the Food and Drug Administration (FDA) has approved its manufacturing plant in Framingham, Mass., for the production of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5631188 Tue, 24 Jan 2012 15:13:17 +0100 5631188 http://www.medworm.com/index.php?rid=5621702&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fp-17I2Le7Dc%2Fboston-scientific-announces-favorable-ruling-patent-infringement-case-36032.html Johnson and Johnson's patents found invalid NATICK, Mass., Jan. 23, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces that the U.S. District Court for the District of New Jersey has found all the asserted patents in a suit... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5621702 Mon, 23 Jan 2012 20:49:38 +0100 5621702 http://www.medworm.com/index.php?rid=5621703&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FdaCkM0XMYGY%2Fnovo-nordisk-establishes-type-1-diabetes-r-amp-d-center-seattle-36033.html   PRINCETON, N.J., Jan. 23, 2012 /PRNewswire/ -- Novo Nordisk (NYSE:NVO) announced today that the company will establish a type 1 diabetes research and development center in Seattle, Wash., U.S. The new center will combine Novo Nordisk's... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5621703 Mon, 23 Jan 2012 20:08:47 +0100 5621703 http://www.medworm.com/index.php?rid=5621704&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FYBYDqmFbuVU%2Fcapstone-therapeutics-announces-operational-update-36029.html TEMPE, Ariz., Jan. 20, 2012 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) (the "Company") announced today additional steps it has taken to preserve cash and move toward winding down operations. Capstone will cease clinical development of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5621704 Mon, 23 Jan 2012 17:07:10 +0100 5621704 http://www.medworm.com/index.php?rid=5612231&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FEVl_8cF99-E%2Fresearch-chemist-global-pharmaceutical-pleads-guilty-theft-trade-secrets-35980.html TRENTON, N.J. – A former research chemist with global pharmaceutical company sanofi-aventis (“sanofi”) admitted today to stealing sanofi’s trade secrets and making them available for sale through Abby Pharmatech,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612231 Thu, 19 Jan 2012 15:30:40 +0100 5612231 http://www.medworm.com/index.php?rid=5612232&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FDKRmM3W-qnQ%2Fpaula-deen-pledges-money-diabetes-association-35977.html NEW YORK (AP) - Celebrity chef Paula Deen on Wednesday pledged a portion of her earnings from a lucrative endorsement deal with a diabetes drugmaker to the nonprofit American Diabetes Association. The queen of Southern cooking and author of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612232 Thu, 19 Jan 2012 13:45:05 +0100 5612232 http://www.medworm.com/index.php?rid=5612233&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F9dSYZ64exNo%2Fannouncement-basic-agreement-concerning-co-promotion-anti-depressant-paxil-cr-35974.html TOKYO, Jan 19, 2012 - GlaxoSmithKline K.K. (President: Philippe Fauchet, Head Office: Shibuya-ku, Tokyo, hereinafter referred to as GSK) and Dainippon Sumitimo Pharma Co, Ltd. (President: Masayo Tada, Head Office: Chuo-ku, Osaka, hereinafter... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612233 Thu, 19 Jan 2012 13:21:50 +0100 5612233 http://www.medworm.com/index.php?rid=5612234&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F591dyu-qUR4%2Fbayer-healthcare-expands-minnesolta-35975.html Jan. 19--Bayer HealthCare on Wednesday announced the opening of a new and expanded facility in Coon Rapids that nearly doubles its space in Minnesota. The facility houses Bayer's Interventional franchise and features new research and development... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612234 Thu, 19 Jan 2012 13:17:16 +0100 5612234 http://www.medworm.com/index.php?rid=5612235&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FvwFEyrJAaYM%2Fsandoz-initiates-two-more-phase-iii-biosimilar-trials-reinforcing-long-term-global-leadership-35976.html     Phase III clinical study for filgrastim biosimilar (Neupogen®)[1] is expected to support expansion to the US market     Phase III study for Sandoz pegfilgrastim (Neulasta®) represents next major step in... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612235 Thu, 19 Jan 2012 12:49:05 +0100 5612235 http://www.medworm.com/index.php?rid=5612236&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FSP6f66wSFKM%2Fjazz-pharmaceuticals-azur-pharma-combine-create-jazz-pharmaceuticals-plc-35961.html DUBLIN, Jan. 18, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the closing of the business combination of Jazz Pharmaceuticals, Inc. and Azur Pharma plc.  The two companies have combined to create... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612236 Wed, 18 Jan 2012 15:20:42 +0100 5612236 http://www.medworm.com/index.php?rid=5612237&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FIMZQGu1ySnA%2Fnovartis-receives-chinese-ok-eye-lucentis-35957.html From Associated Press (January 18, 2012) Swiss drugmaker Novartis said Wednesday that it received Chinese regulatory approval for its eye drug Lucentis, and it is launching the diabetes treatment Galvus in China. Lucentis treats wet age-related... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612237 Wed, 18 Jan 2012 13:14:38 +0100 5612237 http://www.medworm.com/index.php?rid=5612238&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FH-SYzXjOixQ%2Fshire-slips-rivals-production-problems-look-set-ease-35959.html Shire has come under pressure on a renewed competitive threat to one of its key drugs. Its Replagal treatment for Fabry disease has seen a boost to its sales following manufacturing problems at competitor Genzyme, which makes the rival drug... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612238 Wed, 18 Jan 2012 13:01:15 +0100 5612238 http://www.medworm.com/index.php?rid=5612239&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fp04mc9bSpUA%2Fcolumbia-labs-plummets-negative-fda-review-35960.html WASHINGTON (AP) ? Shares of Columbia Laboratories plummeted more than 50 percent Tuesday after federal drug reviewers said the company's hormone-based gel appears to be ineffective for preventing premature birth. Shares of the Livingston, N.J.-based... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612239 Wed, 18 Jan 2012 13:01:06 +0100 5612239 http://www.medworm.com/index.php?rid=5612240&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FmEum99qa2S8%2Fgenzyme-announces-european-approval-framingham-manufacturing-plant-35958.html CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 18, 2012 - Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that the European Medicines Agency (EMA) has approved its manufacturing plant in Framingham, Mass., for the production of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612240 Wed, 18 Jan 2012 13:00:47 +0100 5612240 http://www.medworm.com/index.php?rid=5612241&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fo4KTkR66ZWo%2Ftakeda-announces-strategic-measures-achieve-efficiencies-long-term-growth-35950.html OSAKA, Japan, January 18, 2012 – Takeda Pharmaceutical Company Limited (“Takeda”, TSE: 4502) announced today strategic measures to better align its global workforce and consolidate site operations in order to integrate legacy... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612241 Wed, 18 Jan 2012 12:49:12 +0100 5612241 http://www.medworm.com/index.php?rid=5612242&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F1AhfxLmhRDQ%2Fims-signs-agreement-divest-sdi-medical-promotional-audits-35952.html DANBURY, Conn.--(BUSINESS WIRE)--Jan 17, 2012 - IMS Health announced today that it has entered into an agreement with inVentiv Health to divest certain promotional and medical market research products of SDI Health, a Pennsylvania-based healthcare... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612242 Wed, 18 Jan 2012 12:29:40 +0100 5612242 http://www.medworm.com/index.php?rid=5612243&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FyBAadVMe3lE%2Ftakeda-announces-strategic-measures-achieve-efficiencies-long-term-growth-35951.html OSAKA, Japan, January 18, 2012, 2012 – Takeda Pharmaceutical Company Limited (“Takeda”, TSE: 4502) announced today strategic measures to better align its global workforce and consolidate site operations in order to integrate legacy... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5612243 Wed, 18 Jan 2012 12:17:16 +0100 5612243 http://www.medworm.com/index.php?rid=5600117&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FJ_D1I_GHa7c%2F42-percent-online-consumers-think-pharma-companies-should-involved-online-health-communities-35929.html – ADD/ADHD and Bipolar Disorder Caregivers Top Groups to Agree ePharma Consumer® Study Reveals New Trends around How Consumers Interact with Pharma, Including Customer Service Options, Patient Education, and Pharma Websites – Webinar... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5600117 Tue, 17 Jan 2012 15:37:51 +0100 5600117 http://www.medworm.com/index.php?rid=5600118&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FECtMKWjLUj4%2Fvaleant-boosts-bid-ista-pharmaceuticals-us-7-50-per-share-6-50-35930.html From Canadian Press DataFile (January 17, 2012) MISSISSAUGA, Ont. _ Valeant Pharmaceuticals International Inc. (TSX:VRX) is sweetening its hostile bid for Irvine, Calif.,-based ISTA Pharmaceuticals Inc. Valeant's new offer raises its earlier bid by... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5600118 Tue, 17 Jan 2012 15:25:50 +0100 5600118 http://www.medworm.com/index.php?rid=5600119&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FNmk3pxcAs60%2Fpfizer-medivation-end-development-deal-35931.html NEW YORK (AP) - Drug developers Pfizer Inc. and Medivation Inc. said Tuesday that they are ending development of a potential Alzheimer's disease treatment after the drug yielded disappointing results in another late-stage clinical study. The... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5600119 Tue, 17 Jan 2012 14:11:51 +0100 5600119 http://www.medworm.com/index.php?rid=5600120&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FVB-Fe7roeG0%2Fpaula-deen-teams-novo-nordisk-diabetes-35937.html Celebrity chef and Food Network star Paula Deen is teaming with drugmaker Novo Nordisk to launch a program that aims to help people live with Type 2 diabetes and promote a Novo diabetes drug. The program is called Diabetes in a New Light and... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5600120 Tue, 17 Jan 2012 14:01:23 +0100 5600120 http://www.medworm.com/index.php?rid=5600121&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F4zIiUFZfM3E%2Fastex-announces-early-transfer-epigenetics-project-gsk-35938.html Astex’s Pyramid™ Drug Discovery Collaboration With GSK on Multiple Targets Across Multiple Therapeutics Areas Continues DUBLIN, Calif., January 16, 2011 – Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) today announced that the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5600121 Tue, 17 Jan 2012 13:58:39 +0100 5600121 http://www.medworm.com/index.php?rid=5600122&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FQg3dKFTBBkM%2Fforest-laboratories-inc-reports-fiscal-year-third-quarter-2012-earnings-per-share-1-04-35932.html NEW YORK--(BUSINESS WIRE)--Jan 17, 2012 - Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that reported earnings per share were $1.04 in the third quarter of fiscal 2012. Reported... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5600122 Tue, 17 Jan 2012 13:26:00 +0100 5600122 http://www.medworm.com/index.php?rid=5600123&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Ff-NW1bRC96I%2Fjanssen-research-amp-development-llc-opens-janssen-labs-san-diego-35934.html Novel Life Science Innovation Center to spur science by supporting early-stage life science industry SAN DIEGO, Jan. 17, 2012 /PRNewswire/ -- Janssen Research & Development, LLC, (Janssen) today opens Janssen Labs at San Diego,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5600123 Tue, 17 Jan 2012 13:20:12 +0100 5600123 http://www.medworm.com/index.php?rid=5600124&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FgIgUtAwGJJY%2Fnovo-nordisk-partners-paula-deen-sons-bobby-jamie-deen-national-diabetes-initiative-35933.html Paula Deen encourages others to see Diabetes in a New Light™, as she shares her personal diabetes story for the first time PRINCETON, N.J., Jan. 17, 2012 /PRNewswire/ -- Novo Nordisk, the world leader in diabetes care, is teaming up... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5600124 Tue, 17 Jan 2012 13:01:18 +0100 5600124 http://www.medworm.com/index.php?rid=5600125&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FnTLTaeBE2YM%2Fcompanies-disclose-doctor-payments-35935.html From UPI Health News (Business) (January 17, 2012) Healthcare reform legislation enacted in 2010 requires drug companies to disclose payments made to physicians who are not their employees, U.S. officials say. The provision in the Affordable Care... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5600125 Tue, 17 Jan 2012 12:08:33 +0100 5600125 http://www.medworm.com/index.php?rid=5600126&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FGH23G2JXakw%2Fconstellation-pharmaceuticals-genentech-enter-broad-epigenetics-discovery-collaboration-35936.html CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 17, 2012 - Constellation Pharmaceuticals, Inc., today announced that it has entered into a major strategic agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to launch a broad... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5600126 Tue, 17 Jan 2012 11:40:55 +0100 5600126 http://www.medworm.com/index.php?rid=5586102&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F5he-HXSNIPs%2Fklobuchar-warns-makers-over-tactics-limit-supplies-35882.html Klobuchar warns drugmakers over tactics that limit supplies [Star Tribune, Minneapolis] From Star Tribune (Minneapolis, MN) (January 13, 2012)   Jan. 13--U.S. Sen. Amy Klobuchar is taking on the pharmaceutical industry over the problem of drug... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586102 Fri, 13 Jan 2012 14:17:54 +0100 5586102 http://www.medworm.com/index.php?rid=5586103&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F30NK6KZxkXU%2Fpenn-s-cancer-institute-suing-former-top-aide-his-firm-theft-intellectual-property-35883.html   Jan. 13--The University of Pennsylvania's cancer research institute is suing its former scientific director and a biotechnology company he founded for more than $1 billion, accusing him of stealing intellectual property and trying to profit... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586103 Fri, 13 Jan 2012 14:05:49 +0100 5586103 http://www.medworm.com/index.php?rid=5586104&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FdJ-ooiLddjQ%2Ffda-advisors-endorsed-contraceptive-had-industry-ties-35885.html The Food and Drug Administration (FDA) should disregard a joint advisory committee’s support of a controversial birth control pill because four members of the panel had ties to either the contraceptive maker or the maker of a generic version,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586104 Fri, 13 Jan 2012 14:01:27 +0100 5586104 http://www.medworm.com/index.php?rid=5586105&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FFQllFHC5jwc%2Fnovartis-cut-almost-2-000-us-jobs-year-35877.html [Associated Press]   Published Date: January 13, 2012 03:14:00 AM EST GENEVA (AP) - Drug maker Novartis will cut 1,960 jobs in the United States this year in anticipation of lower sales for two of its hypertension drugs, the Swiss company said... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586105 Fri, 13 Jan 2012 13:28:43 +0100 5586105 http://www.medworm.com/index.php?rid=5586106&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FpzfFTUxkcfg%2Fotsuka-pharmaceutical-ucb-focus-collaboration-area-central-nervous-cns-disorders-35878.html Collaboration between Otsuka and UCB in the therapeutic area of immunology to discontinue UCB to further develop its immunology pipeline in Japan, starting with plans to bring certolizumab pegol to rheumatoid arthritis (RA) patients in... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586106 Fri, 13 Jan 2012 13:21:33 +0100 5586106 http://www.medworm.com/index.php?rid=5586107&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F0hridT6-f4w%2Fnuron-biotech-licenses-hibtiter-vaccine-mitsubishi-tanabe-pharma-corporation-japanese-market-35884.html EXTON, Pa.--(BUSINESS WIRE)--Jan 13, 2012 - Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has licensed its HibTITER® vaccine to Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586107 Fri, 13 Jan 2012 13:13:31 +0100 5586107 http://www.medworm.com/index.php?rid=5586108&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FPdjrfATWNI4%2Fnovartis-restructure-us-business-strengthen-competitive-position-light-loss-diovan-patent-announces-35876.html • US General Medicines restructuring results in reduction of 1,960 positions • Action reflects impending loss of Diovan patent exclusivity in US and expected impact on worldwide sales of Rasilez/Tekturna after ALTITUDE study... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586108 Fri, 13 Jan 2012 12:01:58 +0100 5586108 http://www.medworm.com/index.php?rid=5586109&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FTdkEUYdYkx0%2Fhealth-care-spending-has-slow-growth-rate-again-2010-35862.html [Daily Oklahoman (Oklahoma City)] Published Date: January 10, 2012 03:12:00 AM EST Author: By Chris Casteel, The Oklahoman, Oklahoma City Jan. 10--WASHINGTON -- Health care spending in the United States grew slowly for a second straight year in... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586109 Thu, 12 Jan 2012 15:06:10 +0100 5586109 http://www.medworm.com/index.php?rid=5586110&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fjwtj_kczceY%2Fmylan-sued-over-version-diabetes-35861.html BRIEF: Mylan sued over generic version of diabetes drug [Pittsburgh Tribune-Review (PA)] Published Date: January 10, 2012 02:05:00 AM EST Author: The Pittsburgh Tribune-Review Jan. 10--Mylan Inc. said it has been sued over plans to sell... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586110 Thu, 12 Jan 2012 14:01:36 +0100 5586110 http://www.medworm.com/index.php?rid=5586111&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FcG4WGlxAu08%2Ffirst-clinical-trial-site-initiated-csl-behring-phase-ii-iii-pivotal-study-recombinant-fusion-35858.html Study follows a Phase I PK trial that showed "very promising" half-life extension results         VIENNA, January 12, 2012, 2012 /PRNewswire/ -- CSL Behring has announced that the first site has been initiated in its global phase II/III,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586111 Thu, 12 Jan 2012 14:01:10 +0100 5586111 http://www.medworm.com/index.php?rid=5586112&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FSLEDIUor86k%2Fquestcor-pharmaceuticals-issues-statement-35860.html ANAHEIM, Calif., Jan. 11, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ:  QCOR) today announced it became aware that an investor blog is preparing to issue a report regarding the Company's marketing and business practices.... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586112 Thu, 12 Jan 2012 14:01:06 +0100 5586112 http://www.medworm.com/index.php?rid=5586113&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FuEatf2SYYE0%2Fcollege-s-find-triggers-pounds-1-6bn-buy-out-35853.html [Western Mail (Wales)] Published Date: January 11, 2012 12:01:00 AM EST Author: Anonymous A PIONEERING drug developed at a Welsh university was yesterday at the centre of a multi-billion-pound company takeover by a US drugs giant. The... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586113 Thu, 12 Jan 2012 13:19:14 +0100 5586113 http://www.medworm.com/index.php?rid=5586114&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F_-sZHJWcw0U%2Fgilead-nears-completion-pharmasset-deal-35852.html [Associated Press] Published Date: January 12, 2012 07:21:00 AM EST FOSTER CITY, Calif. (AP) ? Gilead Sciences has acquired about 95 percent of the outstanding shares in Pharmasset as it draws closer to closing its $11 billion deal for the drug... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586114 Thu, 12 Jan 2012 13:19:08 +0100 5586114 http://www.medworm.com/index.php?rid=5586115&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FqtvNNECEh9Y%2Fkedem-pharmaceuticals-initiates-development-sublingual-anti-cancer-gleevec-35859.html PHOENIX,, Jan. 12, 2012 /PRNewswire/ -- Kedem Pharmaceuticals Inc. (OTCBB: KDMP), a specialty pharmaceutical company with focus on sublingual drug delivery system is pleased to announce that has initiated the development of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586115 Thu, 12 Jan 2012 13:01:19 +0100 5586115 http://www.medworm.com/index.php?rid=5586116&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FFbBX0wZJG5M%2Fsanofi-aventis-lays-off-100-montreal-35854.html French drugmaker Sanofi-aventis lays off 100 in Montreal From Canadian Press DataFile (January 11, 2012) LAVAL, Que. _ About 100 people are being laid off by French pharmaceutical company Sanofi-Aventis in the Montreal area. The layoffs at a... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586116 Thu, 12 Jan 2012 12:58:29 +0100 5586116 http://www.medworm.com/index.php?rid=5586117&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F_hapA4m0H98%2Fgsk-responds-recent-court-ruling-compas-study-mendoza-argentina-35833.html Issued: Wednesday 11 January 2012, London, UK GlaxoSmithKline respectfully disagrees with the recent court ruling in favour of ANMAT (the Argentinean National Administration of Medicines, Food and Medical Technology) on the fine issued to... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586117 Wed, 11 Jan 2012 14:39:51 +0100 5586117 http://www.medworm.com/index.php?rid=5586118&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FGmw-LtNAuxc%2Fbristol-ceo-sees-fruits-transformation-35834.html TRENTON, N.J. (AP) - Bristol-Myers Squibb Co.'s CEO said Tuesday that the company's five-year transformation into a biopharmaceutical company has already brought five new product launches and soon could bring two more approvals, for a new... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586118 Wed, 11 Jan 2012 14:33:40 +0100 5586118 http://www.medworm.com/index.php?rid=5586119&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FnJ-WZNNYAmo%2Fanalyst-gauges-financial-loss-novartis-recall-35835.html From Associated Press (January 10, 2012)   WASHINGTON -- Manufacturing problems at a Novartis factory that triggered the recall of four popular medicines could cost the company between $560 million and $750 million in lost sales... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586119 Wed, 11 Jan 2012 14:06:20 +0100 5586119 http://www.medworm.com/index.php?rid=5586120&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F5W2Ds4Nd0kE%2Fnantworks-buys-old-pfizer-plant-35828.html From Tribune-Star (Terre Haute, IN) (January 11, 2012) Jan. 11--TERRE HAUTE -- California-based NantWorks announced Tuesday it will locate a new pharmaceutical manufacturing plant on former Pfizer Inc. property south of Terre Haute, creating up... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586120 Wed, 11 Jan 2012 12:45:39 +0100 5586120 http://www.medworm.com/index.php?rid=5586121&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F5kKnOxErDao%2Fsurvey-biomedical-industry-ceos-finds-lack-investment-regulatory-environment-threaten-future-growth-35818.html   SAN FRANCISCO, Jan. 10, 2012 – Access to capital, a burdensome and uncertain regulatory environment and lack of innovation and productivity in research and development are the biggest threats to the biomedical industry’s growth... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586121 Tue, 10 Jan 2012 20:32:51 +0100 5586121 http://www.medworm.com/index.php?rid=5586122&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FX0tH3a1XzVw%2Fintroducing-nutritionpossible-new-resource-offers-personalized-nutritional-guidance-achieve-better-35808.html New online resource, powered by the makers of Centrum® multivitamins, helps people stay true to their resolutions by offering a free and easy way to navigate and simplify their nutritional choices MADISON, N.J.--(BUSINESS WIRE)--Millions of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586122 Tue, 10 Jan 2012 15:10:55 +0100 5586122 http://www.medworm.com/index.php?rid=5586123&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FCEvn8AlE24U%2Fdako-amgen-collaborate-development-companion-diagnostic-amgen-investigational-cancer-therapy-35809.html Dako, a world leading independent cancer diagnostic supplier with 45 years of experience in pathology, announced today that it has entered into a development and collaboration agreement with Amgen Inc. (Nasdaq: AMGN) to develop a diagnostic test for... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586123 Tue, 10 Jan 2012 15:03:24 +0100 5586123 http://www.medworm.com/index.php?rid=5586124&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fb13sMBlOXqk%2Fastellas-theravance-announce-termination-license-development-commercialization-agreement-vibativ-35812.html TOKYO, Japan and SOUTH SAN FRANCISCO, CA/January 6, 2012 — Astellas Pharma Inc. (Astellas) (Tokyo:4503) and Theravance, Inc. (NASDAQ: THRX) today announced that Astellas has exercised its right to terminate the global License, Development... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586124 Tue, 10 Jan 2012 15:02:39 +0100 5586124 http://www.medworm.com/index.php?rid=5586125&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F10jxlba8Wp0%2Fucsf-sanofi-collaborate-find-new-diabetes-cures-35807.html JOINTLY RELEASED BY SANOFI AND THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO SAN FRANCISCO, Jan. 10, 2012 /PRNewswire/ -- The University of California, San Francisco (UCSF) has signed an alliance with international pharmaceutical company... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586125 Tue, 10 Jan 2012 15:01:31 +0100 5586125 http://www.medworm.com/index.php?rid=5586126&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FHRdFRE6A2nY%2Fendo-announces-potential-short-term-supply-constraints-certain-analgesic-result-temporary-shut-down-35811.html CHADDS FORD, Pa., Jan. 9, 2012 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that, as a result of a temporary shut-down of Novartis Consumer Health Inc.'s Lincoln, Neb., manufacturing facility, there will be a... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586126 Tue, 10 Jan 2012 15:01:07 +0100 5586126 http://www.medworm.com/index.php?rid=5586127&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fn5MMhFVg6dI%2Fventana-collaborate-pfizer-cst-companion-diagnostic-identify-lung-cancer-patients-alk-gene-35804.html Collaboration a significant step in the war against non-small cell lung cancer (NSCLC)         TUCSON, Jan. 10, 2012  /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586127 Tue, 10 Jan 2012 14:04:11 +0100 5586127 http://www.medworm.com/index.php?rid=5586128&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FlPzuHqIZYa0%2Ffoundation-medicine-announces-collaboration-sanofi-35803.html Fifth Partnership Will Help Translate Cancer Genomic Science to Clinical Results CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 10, 2012 - Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genome analysis to... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586128 Tue, 10 Jan 2012 14:03:48 +0100 5586128 http://www.medworm.com/index.php?rid=5586129&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FcR9dggzw8Rs%2Fxenon-collaborate-genentech-discovery-novel-targeted-pain-therapeutics-35806.html VANCOUVER, British Columbia, Jan. 9, 2012 /CNW/ - Xenon today announced a strategic alliance with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to discover and develop compounds and companion diagnostics for the potential... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586129 Tue, 10 Jan 2012 13:31:38 +0100 5586129 http://www.medworm.com/index.php?rid=5586130&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FrqmS_qsS2-s%2Fendo-pharmaceuticals-opiate-products-novartis-consumer-health-public-health-advisory-potential-35799.html Including the following products: Opana ER (oxymorphone hydrochloride) Extended-Release Tablets CII Opana (oxymorphone hydrochloride) CII Oxymorphone hydrochloride Tablets CII PERCOCET (oxycodone hydrochloride and acetaminophen USP)... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586130 Tue, 10 Jan 2012 13:01:46 +0100 5586130 http://www.medworm.com/index.php?rid=5586131&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FBrG5cdXTUm4%2Fshire-acquires-us-rights-resolor-prucalopride-35810.html Agreement allows development for potential treatment of chronic constipation PHILADELPHIA, January 10, 2012/PRNewswire-FirstCall/ --Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that it has... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586131 Tue, 10 Jan 2012 12:25:01 +0100 5586131 http://www.medworm.com/index.php?rid=5586132&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FiUvzyjT0x1c%2Fforma-therapeutics-announces-exclusive-cancer-discovery-alliance-focused-tumor-metabolism-janssen-35805.html WATERTOWN, Mass.--(BUSINESS WIRE)--Jan 10, 2012 - FORMA Therapeutics today announced an exclusive alliance with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies, in which the two companies will collaborate on the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586132 Tue, 10 Jan 2012 12:10:19 +0100 5586132 http://www.medworm.com/index.php?rid=5586133&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fpvc9PFBnM2A%2Fbayer-healthcare-share-lab-space-start-up-companies-35778.html Dedicated lab space-model at Bayer HealthCare U.S. Innovation Center to be called CoLaborator™ / Shared lab space will help promising life science companies get their start San Francisco, January 9, 2012 – One year after the opening of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586133 Mon, 09 Jan 2012 13:05:56 +0100 5586133 http://www.medworm.com/index.php?rid=5586134&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FBliixzgLfyk%2Fmylan-confirms-first-file-patent-challenge-relating-actoplus-met-xr-35777.html Expects to qualify for 180 days of marketing exclusivity PITTSBURGH, Jan. 9, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that the company has been sued by Takeda Pharmaceutical Company, Watson Pharmaceuticals and Andrx Labs... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586134 Mon, 09 Jan 2012 13:01:21 +0100 5586134 http://www.medworm.com/index.php?rid=5586135&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F0ci2PhzNIPk%2Fastrazeneca-reaffirms-december-2011-financial-guidance-2011-mid-term-planning-assumptions-2010-2014-35774.html Monday, 9 January 2012 During a routine consensus collection process, confidential Company information was inadvertently embedded in a spreadsheet template sent to the sell-side analyst community that follows the Company. This information is out of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586135 Mon, 09 Jan 2012 12:51:20 +0100 5586135 http://www.medworm.com/index.php?rid=5586136&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FXbZG5ZcCyNg%2Fbristol-myers-squibb-acquire-inhibitex-35776.html Strategic Acquisition Supports Long-Term Growth Potential of the Company Builds on Company's Strong Legacy and Commitment in Virology Enhances Company's Broad HCV Portfolio with Addition of INX-189, a potent NS5B Nucleotide NEW YORK &... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586136 Mon, 09 Jan 2012 12:34:22 +0100 5586136 http://www.medworm.com/index.php?rid=5586137&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FSTmDV5acjdQ%2Fnice-needs-more-evidence-new-common-heart-condition-35775.html In preliminary recommendations published today (9 January) NICE is asking Bayer HealthCare for more information on its product rivaroxaban (Xarelto), for the prevention of stroke and systemic embolism in people with atrial fibrillation. Atrial... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586137 Mon, 09 Jan 2012 12:01:48 +0100 5586137 http://www.medworm.com/index.php?rid=5586138&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FTBCRJrZOD1o%2Fgsk-theravance-announce-initial-outcomes-pivotal-phase-iii-studies-once-daily-relovair-copd-asthma-35773.html Issued: Monday 09 January 2012, London UK & South San Francisco, CA, USA   GlaxoSmithKline (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the completion of the phase III registration programme for the once-daily investigational... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5586138 Mon, 09 Jan 2012 12:01:23 +0100 5586138 http://www.medworm.com/index.php?rid=5573522&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FmJt0E6_Za28%2Fdendreon-jumps-4q-provenge-sales-improve-35756.html SEATTLE (AP)-Shares of Dendreon Corp. surged Thursday after the company said sales of its prostate-cancer therapy Provenge continued to grow in the fourth quarter. Dendreon said sales of Provenge rose to $82 million in the fourth quarter. FactSet... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5573522 Fri, 06 Jan 2012 15:42:49 +0100 5573522 http://www.medworm.com/index.php?rid=5573523&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FaIWvkUimetI%2Fcangene-cuts-120-jobs-shakes-up-management-efficiency-drive-35757.html   [Canadian Press DataFile] Published Date: January 5, 2012 06:14:45 PM EST WINNIPEG _ Canadian biotechnology company Cangene Corp. is cutting 120 jobs, or about 17 per cent of its total workforce. The company, one of Canada's oldest and... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5573523 Fri, 06 Jan 2012 15:14:37 +0100 5573523 http://www.medworm.com/index.php?rid=5573524&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FHTTQUYoRF0o%2Ftargacept-alzheimer-s-studies-continue-35755.html NEW YORK (AP)-Targacept Inc. said Thursday that its partner AstraZeneca PLC is preparing to run midstage clinical trials of an experimental Alzheimer's disease treatment that Targacept developed. Targacept said AstraZeneca will study a combination... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5573524 Fri, 06 Jan 2012 14:36:37 +0100 5573524 http://www.medworm.com/index.php?rid=5573525&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FQO2hCVvBj4A%2Fglaxosmithkline-appeal-argentine-vaccine-fines-35754.html BUENOS AIRES, Argentina (AP)-GlaxoSmithKline said Tuesday it will appeal a fine in Argentina involving its development of a vaccine against pneumonia and earaches in small children. The world's second-largest drugmaker was fined $93,000 for protocol... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5573525 Fri, 06 Jan 2012 14:21:41 +0100 5573525 http://www.medworm.com/index.php?rid=5573526&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FUMbI_aus_xY%2Fmerck-ceo-year-better-than-2011-35750.html TRENTON, N.J. (AP) ? Merck & Co.'s CEO said Thursday that setbacks in drug development and other problems made his just-ended first year a tough debut. But Kenneth Frazier expects better news in 2012 for the maker of diabetes blockbuster Januvia... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5573526 Fri, 06 Jan 2012 13:44:40 +0100 5573526 http://www.medworm.com/index.php?rid=5573527&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F6auWzgBGlFs%2Ffda-statement-recently-terminated-clinical-trial-doribax-doripenem-35751.html FDA Statement on recently terminated clinical trial with Doribax (doripenem) Safety Announcement [01-05-2012] The U.S. Food and Drug Administration (FDA) is informing the public that a recent clinical trial with Doribax (doripenem) was stopped... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5573527 Fri, 06 Jan 2012 13:01:09 +0100 5573527 http://www.medworm.com/index.php?rid=5573528&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FYwjZUAReUCc%2Fcangene-announces-workforce-reorganization-35752.html TSX: CNJ Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are in U.S. dollars. TORONTO & WINNIPEG, Jan. 5,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5573528 Fri, 06 Jan 2012 12:54:17 +0100 5573528 http://www.medworm.com/index.php?rid=5573529&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FaOz-pZPBfZI%2Famarin-hits-bumps-road-35747.html From Day, The (New London, CT) (January 6, 2012) Jan. 06--Amarin Corp. plc, a promising biotechnology company whose research-and-development headquarters is moving from Mystic to Groton, has been hit hard in the past six months by patent questions... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5573529 Fri, 06 Jan 2012 12:22:26 +0100 5573529 http://www.medworm.com/index.php?rid=5573530&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fmk2ljMeaEjo%2Fpfizer-inc-s-4-220-layoffs-during-2011-second-most-pharmaceutical-industry-35746.html From Day, The (New London, CT) (January 6, 2012) Jan. 06--For the second year in a row, Pfizer Inc. has been named No. 2 on a list of companies announcing pharmaceutical layoffs. And about a quarter of the 4,220 layoffs revealed by Pfizer last year... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5573530 Fri, 06 Jan 2012 12:22:21 +0100 5573530 http://www.medworm.com/index.php?rid=5573531&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F-yD7qGhOwdo%2Fxoma-streamlines-operations-invest-value-creating-activities-35753.html BERKELEY, Calif., Jan. 5, 2012 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA) today announced it has implemented significant organizational and structural changes that are designed to sharpen the Company's focus on value-creating opportunities... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=5573531 Thu, 05 Jan 2012 18:39:57 +0100 5573531